An experimental cell therapy for Type 1 diabetes has hit a significant milestone, as its developer, Vertex, announced Wednesday the start of initial testing in humans.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,